RXRX Cost of Revenue

Recursion Pharmaceuticals Inc Clas · Cost of Revenue

RXRX logo

RXRX Cost of Revenue

Latest reported$80.45M
RXRX Cost of Revenue ($45.81M → $80.45M)
High-resolution chart · PNG

RXRX cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
120,954,000
45,238,000
42,587,000
48,275,000
0
0
45,809,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.